- CA$92.24m
- CA$78.18m
- -CA$1.08m
- 41
- 45
- 83
- 57
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0 | 1.15 | 2.41 | -1.08 |
Selling / General / Administrative Expenses | ||||
Total Operating Expenses | — | 1.73 | 3.25 | 3.14 |
Operating Profit | 0 | -0.577 | -0.849 | -4.22 |
Net Income Before Taxes | — | -0.577 | -0.849 | -4.22 |
Net Income After Taxes | — | -0.577 | -0.849 | -4.22 |
Net Income Before Extraordinary Items | ||||
Net Income | — | -0.577 | -0.849 | -4.22 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Dilution Adjustment | ||||
Diluted Net Income | 0 | -0.577 | -0.849 | -4.22 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | — | -0.063 | -0.093 | -0.466 |